Eniola's independent CCT model and computational pharmacology work align well with TWAS's goal of enhancing research capacity for early-career scientists in developing countries. His Nigerian nationality and LMIC status make him eligible, though the lack of a current MSc enrollment may limit fit for some TWAS tracks.